{"transactions":[{"id":762040,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock Purchase Warrant","published_at":"2026-05-27T23:23:30.000Z","date":"2026-05-22","kind":"purchase","planned":false,"acquired":true,"shares":14235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased these shares directly from the issuer in a private placement, which purchase is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended."}],"balance_after":18466,"derivative":{"exercise_price":1.28,"exercise_date":"2026-05-22","expiration_date":"2031-11-22","underlying":"Common Stock","underlying_shares":14235},"source":{"system":"sec-edgar","filing":"0001493152-26-025474","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000149315226025474/ownership.xml","form_type":"4"}},{"id":762039,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-27T23:23:30.000Z","date":"2026-05-22","kind":"purchase","planned":false,"acquired":true,"shares":14235,"price":1.405,"value":20000.175,"ownership":{"direct":true},"balance_after":57245,"source":{"system":"sec-edgar","filing":"0001493152-26-025474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000149315226025474/ownership.xml","form_type":"4"}},{"id":1153873,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock Purchase Warrant","published_at":"2025-05-09T21:30:35.000Z","date":"2025-05-07","kind":"purchase","planned":false,"acquired":true,"shares":4231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares are being issued as a portion of and pursuant to the Company entering into a definitive conversion agreement on May 1, 2025, with a conversion date of May 7, 2025,  along with 13 other holders of $6.6 million of the outstanding principal of the Secured Notes to convert the Secured Notes for an aggregate of 253,083 shares of the Company's Common Stock at a conversion price of $26.00 per share (on a post-reverse split basis), issuance of an aggregate of 126,540 warrants each exercisable for one share of Common Stock at an exercise price of $26.00 per share (on a post-reverse split basis), and a portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company."}],"balance_after":4231,"derivative":{"exercise_price":26,"exercise_date":"2025-05-07","expiration_date":"2030-05-07","underlying":"Common Stock","underlying_shares":4231},"source":{"system":"sec-edgar","filing":"0000950170-25-068281","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000095017025068281/ownership.xml","form_type":"4"}},{"id":1153872,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-09T21:30:35.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":8462,"price":26,"value":220012.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares are being issued as a portion of and pursuant to the Company entering into a definitive conversion agreement on May 1, 2025, with a conversion date of May 7, 2025,  along with 13 other holders of $6.6 million of the outstanding principal of the Secured Notes to convert the Secured Notes for an aggregate of 253,083 shares of the Company's Common Stock at a conversion price of $26.00 per share (on a post-reverse split basis), issuance of an aggregate of 126,540 warrants each exercisable for one share of Common Stock at an exercise price of $26.00 per share (on a post-reverse split basis), and a portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company."}],"balance_after":43010,"source":{"system":"sec-edgar","filing":"0000950170-25-068281","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000095017025068281/ownership.xml","form_type":"4"}},{"id":1625666,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-22T19:19:48.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":760714,"price":1.4,"value":1064999.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased these shares directly from the issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended."}],"balance_after":1381909,"source":{"system":"sec-edgar","filing":"0001209191-24-003782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919124003782/doc4.xml","form_type":"4"}},{"id":1756281,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option Grant (Right to Buy)","published_at":"2023-10-23T20:44:10.000Z","date":"2023-10-19","kind":"exercise","planned":false,"acquired":false,"shares":47249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These option shares were part of a stock option grant covering 135,000 shares of common stock. 20% of the total shares subject to the stock option grant vested on October 10, 2020; 20% of the total shares subject to the stock option grant vested on October 10, 2021; 25% of the total shares subject to the stock option grant vested on October 10, 2022; and 35% of the total shares subject to the stock option grant vested on October 10, 2023, subject to her continuous service through the applicable vesting date. The option is subject to additional vesting acceleration pursuant to her Employment Agreement."}],"balance_after":0,"derivative":{"exercise_price":0.14,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":47249},"source":{"system":"sec-edgar","filing":"0001209191-23-053344","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123053344/doc4.xml","form_type":"4"}},{"id":1756280,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-23T20:44:10.000Z","date":"2023-10-19","kind":"exercise","planned":false,"acquired":true,"shares":47249,"price":0.14,"value":6614.86,"ownership":{"direct":true},"balance_after":621195,"source":{"system":"sec-edgar","filing":"0001209191-23-053344","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123053344/doc4.xml","form_type":"4"}},{"id":1780259,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-15T22:52:36.000Z","date":"2023-09-13","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.098,"value":10490.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $2.07 to $2.10. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":573946,"source":{"system":"sec-edgar","filing":"0001209191-23-049650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123049650/doc4.xml","form_type":"4"}},{"id":1782190,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-13T21:33:22.000Z","date":"2023-09-12","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.0884,"value":10442.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the shares of Common Stock is from $2.07 to $2.10. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":568946,"source":{"system":"sec-edgar","filing":"0001209191-23-049314","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123049314/doc4.xml","form_type":"4"}},{"id":1782189,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-13T21:33:22.000Z","date":"2023-09-11","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.0546,"value":10273.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $2.01 to $2.09. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":563946,"source":{"system":"sec-edgar","filing":"0001209191-23-049314","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123049314/doc4.xml","form_type":"4"}},{"id":1784826,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-08T21:25:28.000Z","date":"2023-09-08","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.0222,"value":10111.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the shares of Common Stock is from $1.95 to $2.05. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":558946,"source":{"system":"sec-edgar","filing":"0001209191-23-048824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123048824/doc4.xml","form_type":"4"}},{"id":1784825,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-08T21:25:28.000Z","date":"2023-09-07","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.9484,"value":9742.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $1.90 to $1.95. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":553946,"source":{"system":"sec-edgar","filing":"0001209191-23-048824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123048824/doc4.xml","form_type":"4"}},{"id":1786034,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-07T20:47:49.000Z","date":"2023-09-06","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.9498,"value":9749.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $1.94 to $1.95. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":548946,"source":{"system":"sec-edgar","filing":"0001209191-23-048651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123048651/doc4.xml","form_type":"4"}},{"id":1860873,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-09T22:49:01.000Z","date":"2023-06-09","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.0643,"value":41286.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $1.99 to $2.18. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":543946,"source":{"system":"sec-edgar","filing":"0001209191-23-036040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123036040/doc4.xml","form_type":"4"}},{"id":1862638,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-08T23:24:08.000Z","date":"2023-06-08","kind":"purchase","planned":false,"acquired":true,"shares":4696,"price":2.212,"value":10387.552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the shares of Common Stock is from $2.12 to $2.26. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":523946,"source":{"system":"sec-edgar","filing":"0001209191-23-035581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123035581/doc4.xml","form_type":"4"}},{"id":1862637,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-08T23:24:08.000Z","date":"2023-06-07","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.0316,"value":40632.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $1.90 to $2.16. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":519250,"source":{"system":"sec-edgar","filing":"0001209191-23-035581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123035581/doc4.xml","form_type":"4"}},{"id":1864123,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-07T20:46:36.000Z","date":"2023-06-06","kind":"purchase","planned":false,"acquired":true,"shares":19062,"price":1.8245,"value":34778.619,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the shares of Common Stock is from $1.73 to $1.94. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":499250,"source":{"system":"sec-edgar","filing":"0001209191-23-035121","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123035121/doc4.xml","form_type":"4"}},{"id":1864122,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-07T20:46:36.000Z","date":"2023-06-05","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.6672,"value":33344.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $1.625 to $1.72. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":480188,"source":{"system":"sec-edgar","filing":"0001209191-23-035121","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123035121/doc4.xml","form_type":"4"}},{"id":1873480,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-31T21:33:20.000Z","date":"2023-05-26","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.6598,"value":33196.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the shares of Common Stock is from $1.61 to $1.81. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":460188,"source":{"system":"sec-edgar","filing":"0001209191-23-033173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123033173/doc4.xml","form_type":"4"}},{"id":1873479,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-31T21:33:20.000Z","date":"2023-05-25","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.6174,"value":32348.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $1.57 to $1.69. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":440188,"source":{"system":"sec-edgar","filing":"0001209191-23-033173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123033173/doc4.xml","form_type":"4"}},{"id":1879912,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-24T21:25:37.000Z","date":"2023-05-24","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.6075,"value":32150.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The range of prices for the shares of Common Stock is from $1.52 to $1.70. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":420188,"source":{"system":"sec-edgar","filing":"0001209191-23-031923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123031923/doc4.xml","form_type":"4"}},{"id":1879911,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-24T21:25:37.000Z","date":"2023-05-23","kind":"purchase","planned":false,"acquired":true,"shares":5036,"price":1.5662,"value":7887.3832,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the shares of Common Stock is from $1.57 to $1.60. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":400188,"source":{"system":"sec-edgar","filing":"0001209191-23-031923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123031923/doc4.xml","form_type":"4"}},{"id":1879910,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-24T21:25:37.000Z","date":"2023-05-22","kind":"purchase","planned":false,"acquired":true,"shares":33450,"price":1.526,"value":51044.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $1.50 to $1.54. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":395152,"source":{"system":"sec-edgar","filing":"0001209191-23-031923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919123031923/doc4.xml","form_type":"4"}},{"id":2125860,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option Grant (Right to Buy)","published_at":"2022-11-03T21:09:22.000Z","date":"2022-11-02","kind":"exercise","acquired":false,"shares":33750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These option shares were part of a stock option grant covering 135,000 shares of common stock. 20% of the total shares subject to the stock option grant vested on October 10, 2020; 20% of the total shares subject to the stock option grant vested on October 10, 2021; 25% of the total shares subject to the stock option grant will vest on October 10, 2022; and 35% of the total shares subject to the stock option grant will vest on October 10, 2023, subject to her continuous service through the applicable vesting date. The option is subject to additional vesting acceleration pursuant to her Employment Agreement."}],"balance_after":47249,"derivative":{"exercise_price":0.14,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":33750},"source":{"system":"sec-edgar","filing":"0001209191-22-055548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919122055548/doc4.xml","form_type":"4"}},{"id":2125859,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-03T21:09:22.000Z","date":"2022-11-02","kind":"exercise","acquired":true,"shares":33750,"price":0.14,"value":4725.0,"ownership":{"direct":true},"balance_after":361702,"source":{"system":"sec-edgar","filing":"0001209191-22-055548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919122055548/doc4.xml","form_type":"4"}},{"id":2158531,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-15T20:27:03.000Z","date":"2022-09-14","kind":"purchase","acquired":true,"shares":15000,"price":2.5767,"value":38650.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $2.51 to $2.58. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":327952,"source":{"system":"sec-edgar","filing":"0001209191-22-050074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919122050074/doc4.xml","form_type":"4"}},{"id":2159488,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-14T19:22:54.000Z","date":"2022-09-13","kind":"purchase","acquired":true,"shares":15000,"price":2.5767,"value":38650.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the shares of Common Stock is from $2.58 to $2.63. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":312952,"source":{"system":"sec-edgar","filing":"0001209191-22-049866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919122049866/doc4.xml","form_type":"4"}},{"id":2159487,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-14T19:22:54.000Z","date":"2022-09-12","kind":"purchase","acquired":true,"shares":15000,"price":2.6509,"value":39763.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $2.62 to $2.68. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":297952,"source":{"system":"sec-edgar","filing":"0001209191-22-049866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919122049866/doc4.xml","form_type":"4"}},{"id":2169113,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-01T20:01:46.000Z","date":"2022-08-31","kind":"purchase","acquired":true,"shares":10000,"price":2.5572,"value":25572.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the shares of Common Stock is from $2.56 to $2.58. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":282952,"source":{"system":"sec-edgar","filing":"0001209191-22-048239","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919122048239/doc4.xml","form_type":"4"}},{"id":2169112,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-01T20:01:46.000Z","date":"2022-08-30","kind":"purchase","acquired":true,"shares":7200,"price":2.5474,"value":18341.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $2.53 to $2.56. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":272952,"source":{"system":"sec-edgar","filing":"0001209191-22-048239","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919122048239/doc4.xml","form_type":"4"}},{"id":2170876,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-30T21:20:28.000Z","date":"2022-08-29","kind":"purchase","acquired":true,"shares":10000,"price":2.5662,"value":25662.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the shares of Common Stock is from $2.56 to $2.61. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":265752,"source":{"system":"sec-edgar","filing":"0001209191-22-048016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919122048016/doc4.xml","form_type":"4"}},{"id":2170875,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-30T21:20:28.000Z","date":"2022-08-26","kind":"purchase","acquired":true,"shares":10000,"price":2.5358,"value":25358.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $2.48 to $2.60. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":255752,"source":{"system":"sec-edgar","filing":"0001209191-22-048016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919122048016/doc4.xml","form_type":"4"}},{"id":2173022,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-26T20:48:15.000Z","date":"2022-08-25","kind":"purchase","acquired":true,"shares":40300,"price":2.5936,"value":104522.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the shares of Common Stock is from $2.55 to $2.75. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":245752,"source":{"system":"sec-edgar","filing":"0001209191-22-047721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919122047721/doc4.xml","form_type":"4"}},{"id":2173021,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-26T20:48:15.000Z","date":"2022-08-24","kind":"purchase","acquired":true,"shares":50000,"price":2.5045,"value":125225.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $2.23 to $2.60. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":205452,"source":{"system":"sec-edgar","filing":"0001209191-22-047721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919122047721/doc4.xml","form_type":"4"}},{"id":2231631,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-15T23:13:58.000Z","date":"2022-06-14","kind":"purchase","acquired":true,"shares":58856,"price":2.4634,"value":144985.8704,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the shares of Common Stock is from $2.01 to $2.66. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":155452,"source":{"system":"sec-edgar","filing":"0001209191-22-037110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919122037110/doc4.xml","form_type":"4"}},{"id":2231630,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-15T23:13:58.000Z","date":"2022-06-13","kind":"purchase","acquired":true,"shares":7596,"price":2.0817,"value":15812.5932,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $1.99 to $2.2. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":96596,"source":{"system":"sec-edgar","filing":"0001209191-22-037110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919122037110/doc4.xml","form_type":"4"}},{"id":2494355,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option Grant (Right to Buy)","published_at":"2021-11-26T17:17:49.000Z","date":"2021-11-23","kind":"exercise","acquired":false,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These option shares were part of a stock option grant covering 135,000 shares of common stock. 20% of the total shares subject to the stock option grant vested on October 10, 2020; 20% of the total shares subject to the stock option grant vested on October 10, 2021; 25% of the total shares subject to the stock option grant will vest on October 10, 2022; and 35% of the total shares subject to the stock option grant will vest on October 10, 2023, subject to her continuous service through the applicable vesting date. The option is subject to additional vesting acceleration pursuant to her Employment Agreement."}],"balance_after":80999,"derivative":{"exercise_price":0.14,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001209191-21-066900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919121066900/doc4.xml","form_type":"4"}},{"id":2494354,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-26T17:17:49.000Z","date":"2021-11-23","kind":"exercise","acquired":true,"shares":27000,"price":0.14,"value":3780.0,"ownership":{"direct":true},"balance_after":89000,"source":{"system":"sec-edgar","filing":"0001209191-21-066900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919121066900/doc4.xml","form_type":"4"}},{"id":2573419,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-10T21:53:33.000Z","date":"2021-08-19","kind":"purchase","acquired":true,"shares":10000,"price":4.3979,"value":43979.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $4.17 to $4.68. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":62000,"source":{"system":"sec-edgar","filing":"0001209191-21-055532","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919121055532/doc4a.xml","form_type":"4/A","original_submission_date":"2021-08-23"}},{"id":2573418,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-10T21:52:18.000Z","date":"2021-09-08","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest as follows: 20% will vest on September 8, 2022, 20% will vest on September 8, 2023, 25% will vest on September 8, 2024 and 35% will vest on September 8, 2025."}],"balance_after":80000,"derivative":{"exercise_price":4.31,"expiration_date":"2031-09-07","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-21-055531","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919121055531/doc4.xml","form_type":"4"}},{"id":2573417,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-10T21:52:18.000Z","date":"2021-08-29","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as follows: 33% will vest on July 22, 2022, 33% will vest on July 22, 2023 and 34% will vest on July 22, 2024."}],"balance_after":135000,"derivative":{"exercise_price":4,"expiration_date":"2031-08-28","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001209191-21-055531","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919121055531/doc4.xml","form_type":"4"}},{"id":2593711,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-23T23:50:42.000Z","date":"2021-08-19","kind":"purchase","acquired":true,"shares":10000,"price":4.3979,"value":43979.0,"ownership":{"direct":true},"balance_after":62000,"source":{"system":"sec-edgar","filing":"0001209191-21-053049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919121053049/doc4.xml","form_type":"4"}},{"id":2626118,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":43836,"kind":"person","name":"Byam Rebecca","position":1,"cik":"0001866256","reported_name":"Byam Rebecca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-07-23T23:28:18.000Z","date":"2021-07-22","kind":"purchase","acquired":true,"shares":25000,"price":8,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock purchased in connection with the Issuer's initial public offering for consideration of $8.00 per share."}],"balance_after":52000,"source":{"system":"sec-edgar","filing":"0001209191-21-048079","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866256/000120919121048079/doc4.xml","form_type":"4"}}]}